MCDERMOTT WILL & SCHULTE LLP for ISIS PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member) |
| STEPHEN M RYAN | Deputy Counsel, President's Commission on |
| KAREN SEALANDER | — |
Pharmacy PHA
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member). |
| STEPHEN M RYAN | Organized Crime. |
| KAREN SEALANDER | — |
Medical/Disease Research/Clinical Labs MED
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member). |
| STEPHEN M RYAN | Organized Crime. |
| KAREN SEALANDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.